Separate and combined effects of DNMT and HDAC inhibitors in treating human multi-drug resistant osteosarcoma HosDXR150 cell line.
Understanding the molecular mechanisms underlying multi-drug resistance (MDR) is one of the major challenges in current cancer research. A phenomenon which is common to both intrinsic and acquired resistance, is the aberrant alteration of gene expression in drug-resistant cancers. Although such dysr...
Guardado en:
Autores principales: | Enrico Capobianco, Antonio Mora, Dario La Sala, Annalisa Roberti, Nazar Zaki, Elarbi Badidi, Monia Taranta, Caterina Cinti |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/84351f9cd5a14e0cadcf2ba8d4133153 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Opvækst hos fædre
por: Mogens Nygaard Christoffersen
Publicado: (1997) -
Språkkompetanse hos voksne innvandrere i helsefagarbeiderutdanningen
por: Tove Andersen
Publicado: (2021) -
Newly engineered magnetic erythrocytes for sustained and targeted delivery of anti-cancer therapeutic compounds.
por: Caterina Cinti, et al.
Publicado: (2011) -
Metabolism, HDACs, and HDAC Inhibitors: A Systems Biology Perspective
por: Jacob King, et al.
Publicado: (2021) -
DNMT3A and DNMT3B Targeting as an Effective Radiosensitizing Strategy in Embryonal Rhabdomyosarcoma
por: Simona Camero, et al.
Publicado: (2021)